CDK4 and neoplasm: Additionally, in immune-reconstituted xenograft models, combined PI3Kα and CDK4/6 inhibition has been associated with remodeling of the tumor immune microenvironment, including increased CD8+ T cell infiltration and enhanced cytotoxic effector markers (such as Granzyme B) (56, 68, 69).